# Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.

> **NCT01824251** · PHASE3 · COMPLETED · sponsor: **Nihon Pharmaceutical Co., Ltd** · enrollment: 49 (actual)

## Conditions studied

- Chronic Inflammatory Demyelinating Polyneuropathy

## Interventions

- **DRUG:** NPB-01

## Key facts

- **NCT ID:** NCT01824251
- **Lead sponsor:** Nihon Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2016-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01824251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01824251, "Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01824251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*